Jefferies Financial Group’s Cytokinetics CYTK Stock Holding History

Jefferies Financial Group’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.3M	Hold	50,000	–	–	0.02%	444
2025 Q4	$3.18M	Hold	50,000	–	–	0.02%	625
2025 Q3	$2.75M	Hold	50,000	–	–	0.01%	540
2025 Q2	$1.65M	Buy	+50,000	New	+$1.74M	0.01%	576
2024 Q2	–	Sell	-11,400	Closed	-$799K	–	1502
2024 Q1	$799K	Sell	11,400 -26,100	-70%	-$2.02M	0.01%	904
2023 Q4	$3.13M	Buy	+37,500	New	+$1.36M	0.02%	543

Other funds holding CYTK

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jefferies Financial Group's CYTK Position: Q1 2025 in Review

Jefferies Financial Group sold out of Cytokinetics (CYTK) in Q1 2025, closing a stake of 12,600 shares — an estimated $593K sold.

Jefferies Financial Group first reported a position in CYTK in Q1 2023 and held it in 6 quarters. The position peaked at $2.24M in Q1 2024. 355 funds tracked by Wall St. Rank hold CYTK as of Q1 2025.

Jefferies Financial Group reported no remaining Cytokinetics position as of Q1 2025 after selling out during the quarter.
Jefferies Financial Group sold 12,600 Cytokinetics shares in Q1 2025, an estimated $593K.
Jefferies Financial Group first reported a position in Cytokinetics in Q1 2023 and held it in 6 quarters.
Jefferies Financial Group's Cytokinetics position peaked at $2.24M in Q1 2024.
355 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2025.

Based on Jefferies Financial Group's 13F filing for Q1 2025, filed 8 May 2025.